Inhibitors of AChE and BChE enzymes are the most valuable approaches to treat neurological diseases including Alzheimer's disease (AD) [16] and possible beneficial applications in the treatment of Parkinson's disease, ataxia and dementia [17]. This evidence concerns the gene ACHE and Alzheimer disease.